BRIEF published on 11/14/2024 at 10:00, 7 days 4 hours ago Deutsche Bank to Launch Additional Tier 1 Capital Instruments Securities Regulation S Deutsche Bank Issuance AT1 Capital
PRESS RELEASE published on 11/14/2024 at 09:55, 7 days 4 hours ago EQS-Adhoc: Deutsche Bank to issue Additional Tier 1 capital instruments Deutsche Bank intends to issue Additional Tier 1 capital instruments to support its Tier 1 leverage ratio. The issuance with a first call date in 2031 aims to meet AT1 requirements Deutsche Bank Additional Tier 1 Capital Instruments Tier 1 Ratio AT1 Requirements
BRIEF published on 08/21/2024 at 22:18, 2 months 30 days ago Deutsche Bank Settles Majority of Postbank Takeover Lawsuit Financial Impact Litigation Settlements Deutsche Bank Postbank Takeover
PRESS RELEASE published on 08/21/2024 at 22:13, 2 months 30 days ago EQS-Adhoc: Deutsche Bank reaches settlements with a large share of the plaintiffs in Postbank takeover litigation matter Deutsche Bank settles with majority plaintiffs in Postbank takeover litigation, agreements reached at 31 euros per share leading to positive profit impact Litigation Settlements Deutsche Bank Postbank Takeover Profit Impact
BRIEF published on 06/03/2024 at 10:06, 5 months 18 days ago Deutsche Bank to Issue Additional Tier 1 Capital Instruments Banking Regulation Deutsche Bank Issuance Additional Tier 1 Capital Instruments
PRESS RELEASE published on 06/03/2024 at 10:01, 5 months 18 days ago EQS-Adhoc: Deutsche Bank to issue Additional Tier 1 capital instruments Deutsche Bank to issue Additional Tier 1 capital instruments, supporting Tier 1 leverage ratio. The issuance is of benchmark size with first call date on October 30, 2029 Deutsche Bank Additional Tier 1 Capital Instruments Leverage Ratio Benchmark Size
BRIEF published on 04/26/2024 at 21:57, 6 months 24 days ago Deutsche Bank Faces Legal Provision After Court Hearing on Postbank Takeover Financial Impact Deutsche Bank Postbank Takeover Legal Provision Court Ruling
PRESS RELEASE published on 04/26/2024 at 21:52, 6 months 24 days ago EQS-Adhoc: Deutsche Bank AG: Deutsche Bank updates on Postbank takeover litigation matter Deutsche Bank provides update on Postbank takeover litigation matter following court hearing, estimating potential impact on profitability and capital ratios Profitability Litigation Takeover Deutsche Bank Postbank
PRESS RELEASE published on 11/09/2023 at 10:47, 1 year ago Deutsche Bank AG Announces Tender Offer for Trust Preferred Securities issued by Deutsche Postbank Funding Trust I and issued by Deutsche Postbank Funding Trust III
PRESS RELEASE published on 11/09/2023 at 10:05, 1 year ago Deutsche Bank announces public tender offer for Deutsche Postbank Funding Trust I & III securities
Published on 11/21/2024 at 14:15, 17 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 32 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 32 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 32 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 16 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 17 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 57 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 34 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 12 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 47 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 47 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
